Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis

European Journal of Pharmacology

Volumn 321, Issue 2, 1997, Pages 181-188

  Okada, Motohiro ^a   Kiryu, Kazuhiro ^a   Kawata, Yuko ^a   Mizuno, Kazuhisa ^a   Wada, Kazumaru ^a   Tasaki, Hiroichi ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Adenosine; Caffeine; Carbamazepine; Dopamine; Microdialysis

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; CAFFEINE; CARBAMAZEPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; ANTICONVULSANTS; CAFFEINE; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; MALE; MICRODIALYSIS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1;

EID: 0031046949     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00938-7     Document Type: Article

References (38)

1. Apfeldorf, W.J. and M.K. Shear, 1993, Caffeine potentiation of taste in panic-disorder patients, Biol. Psychiatry 33, 217.
2. Barraco, R.A. and G.B. Stefano, 1990, Pharmacological evidence for the modulation of monoamine release by adenosine in the invertebrate nervous system, J. Neurochem. 54, 2002.
3. 2A receptors associated with norepinephrine release and their desensitization in the rat nucleus tractus solitarius, J. Neurochem. 65, 1604.
4. Blom, S., 1962, Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G32883), Lancet i, 839.
5. Chu, N.S., 1981, Caffeine- and aminophylline-induced seizures, Epilepsia 22, 85.
6. 1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study, Epilepsia 30, 26.
7. Dunwiddie, T.V. and T. Worth, 1982, Sedative and anticonvulsant effects of adenosine analogs in mouse and rat, J. Pharmacol. Exp. Ther. 220, 70.
8. 2 receptors: studies with the putative selective adenosine antagonist PD115,199 and PD116,948, Psychopharmacology 100, 522.
9. 2) receptors, Psychopharmacology 90, 332.
10. Gilliland, K. and D. Andress, 1981, Ad lib caffeine consumption, symptoms of caffeinism, and academic performance, Am. J. Psychiatry 138, 512.
11. Hornfeldt, C.S. and A.A. Larson, 1994, Adenosine receptors are not involved in theophylline-induced seizures, J. Toxicol. Clin. Toxicol. 32, 257.
12. Juergens, S.U., 1987, Stimultaneous determination of zonisamide and nine other anti-epileptic drugs and metabolites in serum, J. Chromatogr. 385, 233.
13. 3H]acetylcholine release, J. Neurochem. 62, 960.
14. 1 receptor antagonist, with anticonvulsant properties, Int. J. Purine Pyrimidine Res. 3, 45.
15. 2 receptor ligands in different chemoconvulsive rodent models, Eur. J. Pharmacol. 242, 221.
16. Kostopoulos, G., D.K. Veronikis and I. Efthimiou, 1987, Caffeine blocks absence seizures in the tottering mutant mouse, Epilepsia 25, 415.
17. Lee, K.S. and M. Reddington, 1986, Autoradiographic evidence for multiple CNS binding sites for adenosine derivates, Neuroscience 9, 535.
18. 2 receptor agonist CGS21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum, J. Pharmacol. Exp. Ther. 252, 1134.
19. Marangos, P.J., R.M. Post, J. Patel, K. Zander, A. Parma and S. Weiss, 1983, Specific and potent interactions of carbamazepine with brain adenosine receptors, Eur. J. Pharmacol. 93, 175.
20. Masuda, Y., T. Utsui, Y. Shiraishi, T. Karasawa, K. Yoshida and M. Shimizu, 1979, Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine, and 3-sulfamoylmethyl-1,2-benzisoxazole (AD810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals, Epilepsia 20, 623.
21. 2+ current in hippocampal CA3 neurones, Neuron 10, 327.
22. 2+ dependent dopamine release, Epilepsy Res. 13, 113.
23. Okada, M., S. Kaneko, T. Hirano, K. Mizuno, T. Kondo, K. Otani and Y. Fukishima, 1995, Effects of zonisamide on dopaminergic system, Epilepsy Res. 22, 193.
24. Okada, M., K. Mizuno, M. Okuyama and S. Kaneko, 1996, Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum, Psychiatry Clin. Neurosci. 50, 147.
25. Okuma, T., I. Yamashita, R. Takahashi, H. Itoh, S. Otsuki, S. Watanabe, K. Sarai, H. Hazama and K. Inanaga, 1990, Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double blind controlled study, Pharmacopsychiatry 23, 143.
26. Rail, T.W., 1990, Drugs used in the treatment of asthma, in: The Pharmacologic Basis of Therapeutics, eds. A.G. Gilman, T.W. Rail, A.S. Nies and P. Taylor (Pergamon, New York, NY) p. 618.
27. Reddington, M. and K.S. Lee, 1991, Adenosine receptor subtypes: classi-fication and distribution, in: Adenosine in the Nervous System, ed. T.W. Stone (Academic Press, London) p. 77.
28. Skerritt, J.H., L.P. Davies and G.A. Johnston, 1983, Interaction of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies, Epilepsia 24, 634.
29. Stone, T.W. and J.T. Bartrup, 1991, Electropharmacology of adenosine, in: Adenosine in the Nervous System, ed. T.W. Stone (Academic Press, London) p. 197.
30. Takahashi, T. and A. Momiyama, 1993, Different types of calcium channels mediate central synaptic transmission, Nature 366, 156.
31. Tondo, L., C. Burrai, L. Scamonatti, F. Toccafondi, A. Poddighe, G. Minnai, A. Tundo and G. Floris, 1989, Carbamazepine in panic disorder, Am. J. Psychiatry 146, 558.
32. Troupin, A.S. and L.M. Ojemann, 1975, Paradoxical intoxication - a complication of anticonvulsant administration, Epilepsia 16, 753.
33. Weaver, D.F., P. Camfield and A. Fraser, 1988, Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes, Neurology 38, 755.
34. 2+ channels in supporting hippocampal synaptic transmission, Science 264, 107.
35. Williams, M., 1989, Adenosine the prototypic neuromodulator, Neurochem. Int. 19, 249.
36. 2 receptors in striatum, Neurosci. Lett. 41, 55.
37. 1 receptor mediation, Neuropharmacology 28, 21.
38. Zetterström, T. and M. Fillenz, 1990, Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release, Eur. J. Pharmacol. 180, 137.